These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

104 related articles for article (PubMed ID: 2879011)

  • 1. The effect of pH and concentration on alpha-methyldopa absorption in man.
    Merfeld AE; Mlodozeniec AR; Cortese MA; Rhodes JB; Dressman JB; Admidon GL
    J Pharm Pharmacol; 1986 Nov; 38(11):815-22. PubMed ID: 2879011
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Concentration and pH dependency of alpha-methyldopa absorption in rat intestine.
    Amidon GL; Merfeld AE; Dressman JB
    J Pharm Pharmacol; 1986 May; 38(5):363-8. PubMed ID: 2872312
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pharmacokinetics of methyldopa in man.
    Kwan KC; Foltz EL; Breault GO; Baer JE; Totaro JA
    J Pharmacol Exp Ther; 1976 Aug; 198(2):264-77. PubMed ID: 781212
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Use of the peptide carrier system to improve the intestinal absorption of L-alpha-methyldopa: carrier kinetics, intestinal permeabilities, and in vitro hydrolysis of dipeptidyl derivatives of L-alpha-methyldopa.
    Hu M; Subramanian P; Mosberg HI; Amidon GL
    Pharm Res; 1989 Jan; 6(1):66-70. PubMed ID: 2717522
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The absorption and conjugation of methyldopa in patients with coeliac and Crohn's diseases during treatment.
    Renwick AG; Higgins V; Powers K; Smith CL; George CF
    Br J Clin Pharmacol; 1983 Jul; 16(1):77-83. PubMed ID: 6882626
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Alpha-methyldopa disposition in mothers with hypertension and in their breast-fed infants.
    White WB; Andreoli JW; Cohn RD
    Clin Pharmacol Ther; 1985 Apr; 37(4):387-90. PubMed ID: 3838502
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Clinical pharmacokinetics of methyldopa.
    Myhre E; Rugstad HE; Hansen T
    Clin Pharmacokinet; 1982; 7(3):221-33. PubMed ID: 7047042
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Intestinal absorption studies on peptide mimetic alpha-methyldopa prodrugs.
    Wang HP; Lu HH; Lee JS; Cheng CY; Mah JR; Ku CY; Hsu W; Yen CF; Lin CJ; Kuo HS
    J Pharm Pharmacol; 1996 Mar; 48(3):270-6. PubMed ID: 8737052
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The absorption and excretion of methyldopa ingested concomitantly with amino acids or food rich in protein.
    Stenbaek O; Myhre E; Rugstad HE; Arnold E; Hansen T
    Acta Pharmacol Toxicol (Copenh); 1982 Mar; 50(3):225-9. PubMed ID: 7090844
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Metabolism of methyldopa in man after oral administration of the pivaloyloxyethyl ester.
    Vickers S; Duncan CA; Ramjit HG; Dobrinska MR; Dollery CT; Gomez HJ; Leidy HL; Vincek WC
    Drug Metab Dispos; 1984; 12(2):242-6. PubMed ID: 6144491
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Plasma concentration of alpha-methyldopa and sulphate conjugate after oral administration of methyldopa and intravenous administration of methyldopa and methyldopa hydrochloride ethyl ester.
    Saavedra JA; Reid JL; Jordan W; Rawlins MD; Dollery CT
    Eur J Clin Pharmacol; 1975 Aug; 8(6):381-6. PubMed ID: 1233238
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Absorption, metabolism and distribution of (14C)-O-methyldopa and (14C)-L-dopa after oral administration to rats.
    Rivera-Calimlim L
    Br J Pharmacol; 1974 Feb; 50(2):259-63. PubMed ID: 4425764
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Alteration of methyldopa absorption, metabolism, and blood pressure control caused by ferrous sulfate and ferrous gluconate.
    Campbell N; Paddock V; Sundaram R
    Clin Pharmacol Ther; 1988 Apr; 43(4):381-6. PubMed ID: 3356082
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Intestinal absorption of alpha-methyldopa: in vitro mechanistic studies in rat small intestinal segments.
    Osiecka I; Cortese M; Porter PA; Borchardt RT; Fix JA; Gardner CR
    J Pharmacol Exp Ther; 1987 Aug; 242(2):443-9. PubMed ID: 3612544
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effect of pH on the oxidation pathway of alpha-methyldopa catalysed by tyrosinase.
    Serna Rodríguez P; Rodríguez López JN; Tudela J; Varón R; García Cánovas F
    Biochem J; 1990 Dec; 272(2):459-63. PubMed ID: 2125208
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Increases in methyldopa absorption and renal excretion after multiple doses.
    Campbell NR; Patrick W
    J Clin Pharmacol; 1992 May; 32(5):450-4. PubMed ID: 1587963
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Ferrous sulfate reduces methyldopa absorption: methyldopa: iron complex formation as a likely mechanism.
    Campbell NR; Campbell RR; Hasinoff BB
    Clin Invest Med; 1990 Dec; 13(6):329-32. PubMed ID: 2078911
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Metabolic disposition of methyldopa in hypertensive and renal-insufficient children.
    O'Dea RF; Mirkin BL
    Clin Pharmacol Ther; 1980 Jan; 27(1):37-43. PubMed ID: 7351116
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pharmacokinetics of the pivaloyloxyethyl (POE) ester of methyldopa, a new prodrug of methyldopa.
    Dobrinska MR; Kukovetz W; Beubler E; Leidy HL; Gomez HJ; Demetriades J; Bolognese JA
    J Pharmacokinet Biopharm; 1982 Dec; 10(6):587-600. PubMed ID: 7182456
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Demonstration of saturation kinetics in the intestinal absorption of vitamin C in man and the guinea pig.
    Nelson EW; Lane H; Fabri PJ; Scott B
    J Clin Pharmacol; 1978 Jul; 18(7):325-35. PubMed ID: 209065
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.